Otros idiomas Pfizer Inc. Sao Paulo

Acciones

Mercado cerrado - Sao Paulo Otros sitios de cotización 22:05:00 17/05/2024			Varia. Cinco días.	Varia. 1 de enero.
36,58 ^BRL	+8,37 %		+1,36 %	+5,48 %

17/05	Pfizer gana 107,5 millones de dólares a AstraZeneca en un juicio por patentes de un fármaco contra el cáncer en EE.UU.	RE
17/05	Actualización del sector: Los valores del sector sanitario, mixtos a última hora de la tarde	MT

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	17/05
Sector Update: Health Care Stocks Mixed Late Afternoon	17/05
Sector Update: Health Care Stocks Softer Friday Afternoon	17/05
Sector Update: Health Care	17/05
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech	17/05
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech	17/05
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	17/05
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports	17/05
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	17/05
Biontech-Chef: Covid-19 bleibt bedeutsames Gesundheitsrisiko	17/05
Investor Whitefort urges Arbutus Biopharma to halt stock sales, find partner	17/05
GSK sells remaining Haleon stake for GBP1.25 billion	17/05
GSK raises $1.5 bln from sale of remaining Haleon stake	17/05
GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update	16/05
GSK will Haleon-Beteiligung im Wert von etwa 1,3 Mrd Pfund verkaufen	16/05
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...	16/05
Sector Update: Health Care Stocks Steady Premarket Thursday	16/05
Sector Update: Health Care	16/05
Correction: Arvinas, Pfizer Breast Cancer Treatment Shows 'Encouraging' Clinical Activity	16/05
Arvinas, Pfizer Breast Cancer Treatment Shows 'Encouraging' Clinical Activity	16/05

No hay resultados para esta búsqueda

Pfizer, Inc.: ¿Un ciclo para nada?

14 de diciembre 2023 a las 16:29

Albert Bourla, Director General de Pfizer (entrevista completa): ARNm, adquisiciones, medicamentos para adelgazaro